Time for endothelial cell proprotein convertase PC5/6 in cardiovascular medicine? Jan FritzschePhilipp Stawowy Clinical Implications 02 September 2011 Pages: 1061 - 1063
The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy Christopher R. SibleyMatthew J. A. Wood Review 13 July 2011 Pages: 1065 - 1077
Cellular and molecular choreography of neutrophil recruitment to sites of sterile inflammation Braedon McDonaldPaul Kubes Review 13 July 2011 Pages: 1079 - 1088
From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension Roxane PaulinAudrey CourboulinSébastien Bonnet Review 15 July 2011 Pages: 1089 - 1101
Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy Chiara MarchesiRachid EssalmaniAnnik Prat Original Article 17 June 2011 Pages: 1103 - 1111
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect Ellen PreußAlexander MuikBoris Fehse Original Article 23 June 2011 Pages: 1113 - 1124
Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum Theo G. M. F. GorgelsJan H. WaarsingArthur A. B. Bergen Original Article Open access 02 July 2011 Pages: 1125 - 1135
Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo Zuzana ZacharJames MarecekPaul M. Bingham Oiginal Article 19 July 2011 Pages: 1137 - 1148
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54 Steven M. RowePeter SloaneDavid M. Bedwell Original Article 22 July 2011 Pages: 1149 - 1161